Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Rapid Dose Therapeutics Corp ( (TSE:DOSE) ) has provided an update.
Rapid Dose Therapeutics Corp., a Canadian biotechnology company specializing in oral thin film drug delivery, is building its QuickStrip portfolio to serve pharmaceutical, nutraceutical and vaccine applications that require rapid and discreet administration. The company continues to list its shares on the Canadian Securities Exchange under the symbol DOSE, maintaining access to its home-market investor base.
The company has begun trading its common shares on the U.S. OTCQB Venture Market under the ticker RDTCF, expanding visibility and access for American healthcare and biotechnology investors. Management says the cross-border listing is intended to enhance liquidity, broaden market participation and support growth, partnerships and commercialization, reinforcing RDT’s positioning within the North American life sciences investment community.
The most recent analyst rating on (TSE:DOSE) stock is a Sell with a C$0.15 price target. To see the full list of analyst forecasts on Rapid Dose Therapeutics Corp stock, see the TSE:DOSE Stock Forecast page.
Spark’s Take on TSE:DOSE Stock
According to Spark, TipRanks’ AI Analyst, TSE:DOSE is a Neutral.
The score is primarily weighed down by weak financial performance (persistent large losses, negative equity, and ongoing cash burn). Technicals add caution with the stock trading below major moving averages and negative MACD, while valuation is difficult to justify with a negative P/E and no dividend yield data.
To see Spark’s full report on TSE:DOSE stock, click here.
More about Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company focused on innovative drug delivery systems. Its flagship QuickStrip product is a thin, orally dissolvable film that can be infused with pharmaceuticals, nutraceuticals and vaccines for rapid sublingual or buccal absorption, targeting fast onset of action across healthcare and wellness markets.
Average Trading Volume: 37,258
Technical Sentiment Signal: Sell
Current Market Cap: C$19.12M
For an in-depth examination of DOSE stock, go to TipRanks’ Overview page.